Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens

Related articles

1. Rational redesign of antigen binding domain improves in vivo efficacy of CD22-CAR T cells

   This article has 8 authors:

   1. Kole R. DeGolier
   2. Zachary H. Walsh
   3. Lillie Leach
   4. Christine Brzezinski
   5. Amanda Novak
   6. Dimiter Dmitrov
   7. M. Eric Kohler
   8. Terry J. Fry

2. CRISPR engineering of armored CAR T cells enables tumor restricted payload delivery with enhanced efficacy and safety

   This article has 29 authors:

   1. Amanda Chen
   2. Kah Min Yap
   3. Joelle Kim
   4. Kevin Sek
   5. Yu-Kuan Huang
   6. Phoebe Dunbar
   7. Volker Wiebking
   8. Jesse Armitage
   9. Isabelle Munoz
   10. Kirsten Todd
   11. Emily Derrick
   12. Dat Nguyen
   13. Junming Tong
   14. Cheok Weng Chan
   15. Joel Lee
   16. Thang Hoang
   17. Thomas Cole
   18. Jasmine Li
   19. Maria N. de Menezes
   20. Christina Scheffler
   21. Jason Waithman
   22. Jane Oliaro
   23. Simon Harrison
   24. Ian Parish
   25. Junyun Lai
   26. Matthew Porteus
   27. Imran House
   28. Phillip Darcy
   29. Paul Beavis

3. Cysteine-Engineered CAR-T Cells to Counter Antigen Escape in B Cell Lymphoma

   This article has 6 authors:

   1. Jost Lühle
   2. Simon Krost
   3. Felix Goerdeler
   4. Christian Seitz
   5. Peter H. Seeberger
   6. Oren Moscovitz